Photo: Siemens Healthineers
Oct. 12, 2026 — Siemens Healthineers announced it ultrasound business plans to concentrate its efforts on cardiovascular interventions, software, artificial intelligence, and partnerships that support physicians in guiding minimally invasive procedures.
This strategic focus aligns with Siemens Healthineers broader ambition to elevate health globally and reflects its conviction that procedural imaging represents a significant opportunity for long-term growth and differentiated value.
Siemens Healthineers is bringing together the Acuson Origin cardiovascular imaging platform, its strength in intracardiac echocardiography (ICE), rapidly evolving software and AI capabilities, and partnerships with cardiovascular device companies to support physicians in increasingly complex cardiovascular interventions. This strategy is designed to help physicians perform more procedures, treat more patients and prepare for the future of cardiovascular care. From trusted 2D imaging to breakthrough real-time 4D ICE, the Siemens Healthineers portfolio supports every stage of electrophysiology and structural heart interventions. As the pioneer of modern intracardiac echocardiography, Siemens Healthineers brings more than 25 years of innovation to a portfolio that continues to help shape the future of cardiac imaging.
“Medicine is evolving, and imaging is increasingly becoming part of therapy, not just diagnosis,” said Sourabh Pagaria, head of Ultrasound, Siemens Healthineers. “By concentrating our ultrasound portfolio on procedural imaging, we can apply our strengths in advanced cardiovascular imaging, ICE, software, AI, and partnerships with cardiovascular device companies to address important clinical needs and create long-term value for physicians, patients, and Siemens Healthineers.”
General Imaging Ultrasound Systems
As of Oct. 12, 2026, Siemens Healthineers will no longer sell general imaging ultrasound systems including the Acuson Sequoia, Redwood, Juniper and Maple. The company will sell procedural ultrasound systems which include the Acuson Origin, P500(ICE) and Freestyle, together with dedicated software and catheters to procedural customers, mainly electrophysiologists and interventional cardiologists.
General imaging ultrasound remains a well-served market with solutions available from multiple established providers. The company will continue to provide service and support for all existing customers in its installed base honoring all contractual and regulatory obligations and providing full lifecycle support, including maintenance, software updates, and transducer availability. By sharpening its focus, Siemens Healthineers is positioning its ultrasound business to help shape the next generation of image-guided cardiovascular therapy.

June 03, 2026 
